Gedeon Richter - PregLem S.A.
Heike Kenngott is an accomplished regulatory affairs professional with extensive experience in the pharmaceutical industry. Currently serving as Vice President of Regulatory Affairs at Gedeon Richter - PregLem S.A. since October 2016, Kenngott previously held significant roles at Merck Serono S.A., including Regulatory Affairs Director for Biosimilars and Director of Global Regulatory Affairs in Endocrinology. Kenngott's career in regulatory affairs began at Serono, progressing from an Associate Manager to an Associate Director, while also gaining experience as a Clinical Compliance Auditor. Earlier roles include serving as Regulatory Affairs Officer at Merck KGaA. Educational qualifications include a Master of Science in Pharmaceutical Medicine from the University of Surrey and a Dipl-Ing (FH) in Chemistry from Fachhochschule Isny.
This person is not in any teams
Gedeon Richter - PregLem S.A.
PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine. The company was founded in 2006 by Ernest Loumaye, a specialist in female reproductive medicine, and Eric Rolin, a finance executive in the pharmaceutical industry. PregLem’s name reflects the company’s goal of addressing unmet needs in gynaecology and infertility and its geographical location near Lake Geneva (“Lac Leman” in French). PregLem is supported by a Scientific Advisory Board comprising the heads of reproductive medicine departments from major European academic institutions. PregLem’s team expertise is in Clinical Product Development, Regulatory Affairs and Sales and Marketing of innovative products in women’s health. On 7th October 2010, Gedeon Richter Plc. announced the acquisition of PregLem SA and PregLem became a member of the Richter Group.